Paper41920375
Targeting neutrophil extracellular traps (NETs): a promising immunotherapeutic approach for pulmonary diseases.
Cai L and 6 others. Mol Biol Rep, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Targeting neutrophil extracellular traps (NETs): a promising immunotherapeutic approach for pulmonary diseases. Papers, record 41920375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41920375
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting neutrophil extracellular traps (NETs): a promising immunotherapeutic approach for pulmonary diseases.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Extracellular Traps | Major topic |
| Lung Diseases | Major topic |
| Neutrophils | Major topic |
| Immunotherapy | Major topic |
| Humans | |
| Animals | |
| Immunity, Innate | |
| Histones |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 82575021 | the National Natural Science Foundation of China | PubMed | ||
| 2408085MH230 | the Science Fund for Anhui Provincial Natural Science Foundation | PubMed | ||
| 2022AH020044 | Distinguished Young Scholars in Universities of Anhui Province | PubMed |
Source PubMed
References100
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39127273 | Peptidylarginine deiminase (PAD): A promising target for chronic diseases treatment. | Int J Biol Macromol | 2024 | https://conductscience.org/library/papers/39127273 | PubMed |
| 2 | 39905519 | "The NET effect": Neutrophil extracellular traps-a potential key component of the dysregulated host immune response in sepsis. | Crit Care | 2025 | https://conductscience.org/library/papers/39905519 | PubMed |
| 3 | 22802447 | Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus. | J Leukoc Biol | 2012 | https://conductscience.org/library/papers/22802447 | PubMed |
| 4 | 39300084 | Neutrophil extracellular traps in homeostasis and disease. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39300084 | PubMed |
| 5 | 20733033 | PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. | J Exp Med | 2010 | https://conductscience.org/library/papers/20733033 | PubMed |
| 6 | 28513453 | Chronic obstructive pulmonary disease. | Lancet | 2017 | https://conductscience.org/library/papers/28513453 | PubMed |
| 7 | 40783798 | The role of long non-coding RNAs in lung cancer metastasis: Molecular mechanisms, pathogenesis and clinical implications. | Clin Transl Med | 2025 | https://conductscience.org/library/papers/40783798 | PubMed |
| 8 | 36979018 | The NADPH Oxidase Inhibitors Apocynin and Diphenyleneiodonium Protect Rats from LPS-Induced Pulmonary Inflammation. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/36979018 | PubMed |
| 9 | 38637878 | Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19. | J Biomed Sci | 2024 | https://conductscience.org/library/papers/38637878 | PubMed |
| 10 | 30279690 | Physiological Stimuli Induce PAD4-Dependent, ROS-Independent NETosis, With Early and Late Events Controlled by Discrete Signaling Pathways. | Front Immunol | 2018 | https://conductscience.org/library/papers/30279690 | PubMed |
| 11 | 34260389 | DNAse-dependent, NET-independent pathway of thrombus formation in vivo. | Proc Natl Acad Sci U S A | 2021 | https://conductscience.org/library/papers/34260389 | PubMed |
| 12 | 40967767 | Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency. | Eur Respir J | 2025 | https://conductscience.org/library/papers/40967767 | PubMed |
| 13 | 17632569 | Beneficial suicide: why neutrophils die to make NETs. | Nat Rev Microbiol | 2007 | https://conductscience.org/library/papers/17632569 | PubMed |
| 14 | 32296583 | Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis. | Cancer Biol Med | 2020 | https://conductscience.org/library/papers/32296583 | PubMed |
| 15 | 36703990 | Alpha-1 antitrypsin limits neutrophil extracellular trap disruption of airway epithelial barrier function. | Front Immunol | 2022 | https://conductscience.org/library/papers/36703990 | PubMed |
| 16 | 41531731 | Neutrophil degranulation in the lung microenvironment linked to idiopathic pulmonary fibrosis severity and survival. | iScience | 2026 | https://conductscience.org/library/papers/41531731 | PubMed |
| 17 | 22817992 | Neutrophil extracellular traps mediate a host defense response to human immunodeficiency virus-1. | Cell Host Microbe | 2012 | https://conductscience.org/library/papers/22817992 | PubMed |
| 18 | 37356776 | Substrate-dependent metabolomic signatures of myeloperoxidase activity in airway epithelial cells: Implications for early cystic fibrosis lung disease. | Free Radic Biol Med | 2023 | https://conductscience.org/library/papers/37356776 | PubMed |
| 19 | 38336251 | Safety, tolerability, pharmacokinetics and neutrophil elastase inhibitory effects of Sivelestat: A randomized, double-blind, placebo-controlled single- and multiple-dose escalation study in Chinese healthy subjects. | Eur J Pharm Sci | 2024 | https://conductscience.org/library/papers/38336251 | PubMed |
| 20 | 10843967 | Neutrophil elastase induces MUC5AC messenger RNA expression by an oxidant-dependent mechanism. | Chest | 2000 | https://conductscience.org/library/papers/10843967 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42875839 | PDHA1 Hyperactivation-Mediated Glucose Metabolism Reprogramming Fuels Neutrophil NETosis and Promotes Acute Lung Injury. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42875839 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41920375
GET https://conductscience.org/api/papers/v1/41920375/references?page=2